BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35347437)

  • 1. PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival.
    Fiz F; Masci C; Costa G; Sollini M; Chiti A; Ieva F; Torzilli G; Viganò L
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3387-3400. PubMed ID: 35347437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic Model.
    Fiz F; Rossi N; Langella S; Ruzzenente A; Serenari M; Ardito F; Cucchetti A; Gallo T; Zamboni G; Mosconi C; Boldrini L; Mirarchi M; Cirillo S; De Bellis M; Pecorella I; Russolillo N; Borzi M; Vara G; Mele C; Ercolani G; Giuliante F; Ravaioli M; Guglielmi A; Ferrero A; Sollini M; Chiti A; Torzilli G; Ieva F; Viganò L
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics nomogram based on optimal VOI of multi-sequence MRI for predicting microvascular invasion in intrahepatic cholangiocarcinoma.
    Ma X; Qian X; Wang Q; Zhang Y; Zong R; Zhang J; Qian B; Yang C; Lu X; Shi Y
    Radiol Med; 2023 Nov; 128(11):1296-1309. PubMed ID: 37679641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model.
    Fiz F; Rossi N; Langella S; Conci S; Serenari M; Ardito F; Cucchetti A; Gallo T; Zamboni GA; Mosconi C; Boldrini L; Mirarchi M; Cirillo S; Ruzzenente A; Pecorella I; Russolillo N; Borzi M; Vara G; Mele C; Ercolani G; Giuliante F; Cescon M; Guglielmi A; Ferrero A; Sollini M; Chiti A; Torzilli G; Ieva F; Viganò L
    Ann Surg Oncol; 2024 May; ():. PubMed ID: 38797789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
    Park HJ; Park B; Park SY; Choi SH; Rhee H; Park JH; Cho ES; Yeom SK; Park S; Park MS; Lee SS
    Eur Radiol; 2021 Nov; 31(11):8638-8648. PubMed ID: 33890153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics analysis of [
    Li Y; Zhang Y; Fang Q; Zhang X; Hou P; Wu H; Wang X
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2599-2614. PubMed ID: 33416951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
    Song JY; Lee YN; Kim YS; Kim SG; Jin SJ; Park JM; Choi GS; Chung JC; Lee MH; Cho YH; Choi MH; Kim DC; Choi HJ; Moon JH; Lee SH; Jeong SW; Jang JY; Kim HS; Kim BS
    Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Jiang C; Zhao L; Xin B; Ma G; Wang X; Song S
    Quant Imaging Med Surg; 2022 Aug; 12(8):4135-4150. PubMed ID: 35919043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A different perspective on
    Vural Topuz Ö; Aksu A; Yılmaz Özgüven MB
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):359-366. PubMed ID: 37088299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.
    Zhou Y; Zhou G; Zhang J; Xu C; Wang X; Xu P
    Eur Radiol; 2021 Sep; 31(9):6846-6855. PubMed ID: 33638019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra and peritumoral PET radiomics analysis to predict the pathological response in breast cancer patients receiving neoadjuvant chemotherapy.
    Aksu A; Güç ZG; Küçüker KA; Alacacıoğlu A; Turgut B
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(3):500002. PubMed ID: 38527731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma.
    Chu H; Liu Z; Liang W; Zhou Q; Zhang Y; Lei K; Tang M; Cao Y; Chen S; Peng S; Kuang M
    Eur Radiol; 2021 Apr; 31(4):2368-2376. PubMed ID: 33033863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence CT radiomics to predict early recurrence of intrahepatic cholangiocarcinoma: a multicenter study.
    Song Y; Zhou G; Zhou Y; Xu Y; Zhang J; Zhang K; He P; Chen M; Liu Y; Sun J; Hu C; Li M; Liao M; Zhang Y; Liao W; Zhou Y
    Hepatol Int; 2023 Aug; 17(4):1016-1027. PubMed ID: 36821045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the microvascular invasion and tumor grading of intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance imaging radiomics and morphological features.
    Chen S; Zhu Y; Wan L; Zou S; Zhang H
    Quant Imaging Med Surg; 2023 Dec; 13(12):8079-8093. PubMed ID: 38106327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of 18F-FDG PET/CT imaging radiomics in the differential diagnosis of single-nodule pulmonary metastases and second primary lung cancer in patients with colorectal cancer.
    Yu Y; Zhu J; Sang S; Yang Y; Zhang B; Deng S
    J Cancer Res Ther; 2024 Apr; 20(2):599-607. PubMed ID: 38687930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
    Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning radiomics to predict the early recurrence of intrahepatic cholangiocarcinoma after curative resection: A multicentre cohort study.
    Bo Z; Chen B; Yang Y; Yao F; Mao Y; Yao J; Yang J; He Q; Zhao Z; Shi X; Chen J; Yu Z; Yang Y; Wang Y; Chen G
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2501-2513. PubMed ID: 36922449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
    Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
    J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal Liver Metastases.
    Xu Y; Ye F; Li L; Yang Y; Ouyang J; Zhou Y; Wang S; Xie L; Zhou J; Zhao H; Zhao X
    Acad Radiol; 2023 Sep; 30(9):2010-2020. PubMed ID: 37414635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.